As of May 9, 2024, the Novartis AG stock's PE ratio is 13.52. This results from the current EPS of $7.41 and stock price of $100.21. The PE ratio has decreased by 34% from the past four quarters average of 20.6.
The PE ratio of Novartis AG has averaged 20.2 over the last ten years. The current price-to-earnings ratio of 13.52 is 33% less than the historical average. In the past ten years, NVS's PE ratio reached its highest point in the Jun 2017 quarter at 30.35, when the stock price was $83.47 and the EPS was $2.75. The lowest point was recorded in the Sep 2022 quarter, when it reached 7.77 with a price of $76.01 and an EPS of $9.78.
Maximum annual increase: 248.1% in 2022
Maximum annual decrease: -69.29% in 2021
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 14.12 | -50.35% |
| 2022 | 28.44 | 248.1% |
| 2021 | 8.17 | -69.29% |
| 2020 | 26.6 | 43.86% |
| 2019 | 18.49 | 17.25% |
| 2018 | 15.77 | -38.4% |
| 2017 | 25.6 | -0.89% |
| 2016 | 25.83 | 122.1% |
| 2015 | 11.63 | -47.16% |
| 2014 | 22.01 | 2.95% |
The current PE ratio of NVS is lower than the 3, 5 and 10-year averages.
NVS's PE ratio is less than its peer stocks MRK and AZN, but it is above JNJ's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 9.82 | $360.64B |
| NVS Novartis AG | 13.52 | $204.47B |
| ABT Abbott Laboratories | 32.41 | $182.09B |
| AZN Astrazeneca plc | 37.86 | $240.62B |
| MRK Merck & Co Inc | 143.11 | $329.85B |
| PFE Pfizer Inc | N/A | $159.68B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $18.12B |
| BMY Bristol Myers Squibb Co | N/A | $90.69B |
NVS stock has a price to earnings ratio of 13.52 as of May 9, 2024.
The 3-year average PE ratio for NVS stock is 17.73.
The 5-year average PE ratio for NVS stock is 19.41.
Over the last ten years, the quarterly PE ratio reached a historic high of 30.35 in the Jun 2017 quarter.
NVS's price to earnings ratio is currently 33% below its 10-year historical average.
The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (May 9, 2024), Novartis AG's stock price is $100.21. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $7.41. Therefore, Novartis AG's price to earnings ratio for today is 13.52. PE RATIO(13.52) = STOCK PRICE($100.21) / TTM EPS($7.41)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.